z-logo
Premium
Identification of a distinct subpopulation of fibroblasts from murine dermis: CD73 − CD105 + as potential marker of dermal fibroblasts subset with multipotency
Author(s) -
Lee Seung Bum,
Shim Sehwan,
Kim MinJung,
Shin HyeYun,
Jang WonSuk,
Lee SunJoo,
Jin YoungWoo,
Lee SeungSook,
Park Sunhoo
Publication year - 2016
Publication title -
cell biology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.932
H-Index - 77
eISSN - 1095-8355
pISSN - 1065-6995
DOI - 10.1002/cbin.10623
Subject(s) - endoglin , dermis , fibroblast , mesenchymal stem cell , dermal fibroblast , microbiology and biotechnology , biology , phenotype , stromal cell , immunology , cell culture , stem cell , anatomy , cancer research , gene , genetics , cd34
Skin dermis includes various types of multipotent stromal cells (MSCs) and a subpopulation of dermal fibroblasts that exhibit the ability to differentiate. However, characterization of this dermal fibroblast subtype remains less understood. In this study, we isolated dermal cells from the skin of newborn C57/B6 mice and investigated their characteristics. Isolated murine dermal cells exhibited a fibroblast phenotype as judged by accepted criteria including a lack of MSC‐related antigens and the differentiation potential of MSCs, and the positive expression of fibroblast markers. A comparative analysis demonstrated that CD73 − CD105 + but not CD73 − CD105 − dermal fibroblasts exhibited some of the functional properties of MSCs. Furthermore, the multipotent phenotype of CD73 − CD105 + cells was diminished by treatment of CD105 siRNA and shRNA, indicating that CD105 expression was critical for the retention of differentiation potential of those cells. Overall, these results suggest that CD73 − CD105 + cells are a distinct subset of dermal fibroblasts with multipotency and that their surface antigens could help to classify this subpopulation. These cells may contribute to the regeneration of damaged tissue.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here